Choreo LLC Has $1.57 Million Stock Holdings in CME Group Inc. (NASDAQ:CME)

Choreo LLC lowered its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 34.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,637 shares of the financial services provider's stock after selling 3,458 shares during the period. Choreo LLC's holdings in CME Group were worth $1,574,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. SJS Investment Consulting Inc. raised its position in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after purchasing an additional 97 shares during the period. Truvestments Capital LLC bought a new position in shares of CME Group in the third quarter worth approximately $26,000. Dunhill Financial LLC lifted its stake in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider's stock worth $27,000 after buying an additional 81 shares in the last quarter. Financial Life Planners bought a new position in shares of CME Group in the fourth quarter worth approximately $32,000. Finally, Fortitude Family Office LLC raised its holdings in shares of CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider's stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Stock Down 0.0 %

NASDAQ CME traded down $0.07 on Tuesday, reaching $241.74. The company had a trading volume of 1,358,984 shares, compared to its average volume of 1,862,481. The firm has a market capitalization of $87.11 billion, a PE ratio of 25.42, a P/E/G ratio of 5.54 and a beta of 0.57. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a 50-day moving average of $235.60 and a 200-day moving average of $224.62. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $249.02.

CME Group declared that its Board of Directors has authorized a share buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board believes its shares are undervalued.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be given a $1.25 dividend. This is a positive change from CME Group's previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 2.07%. CME Group's dividend payout ratio (DPR) is 48.37%.

Analyst Ratings Changes

Several research analysts have recently weighed in on CME shares. Piper Sandler boosted their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an "overweight" rating in a report on Tuesday, January 7th. Keefe, Bruyette & Woods dropped their target price on shares of CME Group from $260.00 to $256.00 and set a "market perform" rating for the company in a research report on Monday, January 13th. Barclays raised their target price on shares of CME Group from $231.00 to $257.00 and gave the stock an "equal weight" rating in a report on Monday, December 9th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $235.00 price target on shares of CME Group in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $227.00 to $226.00 and set a "hold" rating for the company in a research note on Monday, November 11th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $229.27.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.